^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CD70 CAR-T

    i
    Other names: CD70 CAR-T, CD70-targeted CAR-T
    Associations

    News

    Trials
    Company:
    Chongqing Precision Biotech
    Drug class:
    CD70-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    3ms
    Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases (clinicaltrials.gov)
    P1, N=11, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1 trial
    |
    CD70 (CD70 Molecule)
    |
    CD70 CAR-T
    3ms
    Safety and Efficacy of CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors: A Clinical Trial (clinicaltrials.gov)
    P1, N=90, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1 trial
    |
    CD70 (CD70 Molecule)
    |
    cyclophosphamide • fludarabine IV • CD70 CAR-T
    6ms
    A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
    P1, N=30, Recruiting, Weijia Fang, MD | Trial completion date: May 2025 --> May 2027 | Trial primary completion date: May 2024 --> May 2026
    Trial completion date • Trial primary completion date
    |
    CD70 (CD70 Molecule)
    |
    cyclophosphamide • fludarabine IV • CD70 CAR-T
    8ms
    Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE (clinicaltrials.gov)
    P1, N=18, Recruiting, The Children's Hospital of Zhejiang University School of Medicine
    New P1 trial
    |
    CD70 (CD70 Molecule)
    |
    CD70 CAR-T
    almost2years
    A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer (clinicaltrials.gov)
    P1, N=36, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1 trial • Metastases
    |
    CD70 (CD70 Molecule)
    |
    cyclophosphamide • CD70 CAR-T
    over2years
    A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
    P1, N=48, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1 trial • Metastases
    |
    IL6 (Interleukin 6) • CD70 (CD70 Molecule)
    |
    CD70 expression
    |
    cyclophosphamide • CD70 CAR-T
    over3years
    A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
    P1, N=36, Recruiting, Weijia Fang, MD
    New P1 trial
    |
    IL6 (Interleukin 6) • CD70 (CD70 Molecule)
    |
    CD70 expression
    |
    cyclophosphamide • CD70 CAR-T
    over3years
    A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T (clinicaltrials.gov)
    P1, N=48, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1 trial
    |
    IL6 (Interleukin 6) • CD70 (CD70 Molecule)
    |
    CD70 expression
    |
    cyclophosphamide • CD70 CAR-T
    over3years
    A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
    P1, N=36, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1 trial
    |
    IL6 (Interleukin 6) • CD70 (CD70 Molecule)
    |
    CD70 expression
    |
    cyclophosphamide • CD70 CAR-T
    over3years
    A Clinical Study of CD70-targeted CAR-T in the Treatment of Advanced/Metastatic Renal Cell Carcinoma (clinicaltrials.gov)
    P1, N=24, Recruiting, Chongqing Precision Biotech Co., Ltd
    New P1 trial
    |
    IL6 (Interleukin 6) • CD70 (CD70 Molecule)
    |
    CD70 expression
    |
    cyclophosphamide • CD70 CAR-T